- Home
- EB vs PALI Comparison
EB vs PALI Comparison
Compare EB & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EB
- PALI
- Stock Information
- Founded
- EB 2003
- PALI 1996
- Country
- EB United States
- PALI United States
- Employees
- EB N/A
- PALI N/A
- Industry
- EB EDP Services
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EB Technology
- PALI Health Care
- Exchange
- EB Nasdaq
- PALI Nasdaq
- Market Cap
- EB 239.3M
- PALI 212.0M
- IPO Year
- EB 2018
- PALI N/A
- Fundamental
- Price
- EB $2.50
- PALI $2.24
- Analyst Decision
- EB Buy
- PALI Strong Buy
- Analyst Count
- EB 2
- PALI 1
- Target Price
- EB $5.25
- PALI $16.00
- AVG Volume (30 Days)
- EB 673.4K
- PALI 3.9M
- Earning Date
- EB 11-06-2025
- PALI 11-10-2025
- Dividend Yield
- EB N/A
- PALI N/A
- EPS Growth
- EB N/A
- PALI N/A
- EPS
- EB N/A
- PALI N/A
- Revenue
- EB $294,798,000.00
- PALI N/A
- Revenue This Year
- EB N/A
- PALI N/A
- Revenue Next Year
- EB $9.53
- PALI N/A
- P/E Ratio
- EB N/A
- PALI N/A
- Revenue Growth
- EB N/A
- PALI N/A
- 52 Week Low
- EB $1.81
- PALI $0.53
- 52 Week High
- EB $4.12
- PALI $3.30
- Technical
- Relative Strength Index (RSI)
- EB 47.10
- PALI 58.76
- Support Level
- EB $2.44
- PALI $2.11
- Resistance Level
- EB $2.90
- PALI $2.45
- Average True Range (ATR)
- EB 0.13
- PALI 0.23
- MACD
- EB -0.02
- PALI 0.01
- Stochastic Oscillator
- EB 4.35
- PALI 77.01
About EB Eventbrite Inc.
Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.